Cox Terhorst

4.9k total citations · 1 hit paper
61 papers, 4.1k citations indexed

About

Cox Terhorst is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Cox Terhorst has authored 61 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 25 papers in Molecular Biology and 24 papers in Genetics. Recurrent topics in Cox Terhorst's work include T-cell and B-cell Immunology (18 papers), Immune Cell Function and Interaction (17 papers) and Virus-based gene therapy research (14 papers). Cox Terhorst is often cited by papers focused on T-cell and B-cell Immunology (18 papers), Immune Cell Function and Interaction (17 papers) and Virus-based gene therapy research (14 papers). Cox Terhorst collaborates with scholars based in United States, Germany and Spain. Cox Terhorst's co-authors include Roland W. Herzog, Ype P. de Jong, W. Möller, Jamie L. Shirley, Jaime Sancho, Brad E. Hoffman, Richard A. Laursen, Baoping Wang, Thomas Wileman and Massimo Morra and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Cox Terhorst

61 papers receiving 3.9k citations

Hit Papers

Immune Responses to Viral Gene Therapy Vectors 2020 2026 2022 2024 2020 100 200 300 400 500

Peers

Cox Terhorst
Richard J. Bram United States
Russell D. Salter United States
Cécile Chalouni United States
Jim Xiang Canada
Jan Černý Czechia
Peter E. Jensen United States
Edda Fiebiger United States
Richard J. Bram United States
Cox Terhorst
Citations per year, relative to Cox Terhorst Cox Terhorst (= 1×) peers Richard J. Bram

Countries citing papers authored by Cox Terhorst

Since Specialization
Citations

This map shows the geographic impact of Cox Terhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cox Terhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cox Terhorst more than expected).

Fields of papers citing papers by Cox Terhorst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cox Terhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cox Terhorst. The network helps show where Cox Terhorst may publish in the future.

Co-authorship network of co-authors of Cox Terhorst

This figure shows the co-authorship network connecting the top 25 collaborators of Cox Terhorst. A scholar is included among the top collaborators of Cox Terhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cox Terhorst. Cox Terhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rana, Jyoti, Roland W. Herzog, Kentaro Yamada, et al.. (2024). B cell focused transient immune suppression protocol for efficient AAV readministration to the liver. Molecular Therapy — Methods & Clinical Development. 32(1). 101216–101216. 10 indexed citations
2.
Butterfield, John S., Kentaro Yamada, Thaís B. Bertolini, et al.. (2022). IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A mice. Molecular Therapy. 30(12). 3552–3569. 23 indexed citations
3.
Shirley, Jamie L., Ype P. de Jong, Cox Terhorst, & Roland W. Herzog. (2020). Immune Responses to Viral Gene Therapy Vectors. Molecular Therapy. 28(3). 709–722. 537 indexed citations breakdown →
4.
Butterfield, John S., Moanaro Biswas, Jamie L. Shirley, et al.. (2019). TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer. Human Gene Therapy Methods. 30(3). 81–92. 22 indexed citations
5.
Rogers, Geoffrey L., Jamie L. Shirley, Irene Zolotukhin, et al.. (2017). Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells. Blood. 129(24). 3184–3195. 96 indexed citations
6.
Herzog, Roland W., Mario Cooper, George Q. Perrin, et al.. (2017). Regulatory T cells and TLR9 activation shape antibody formation to a secreted transgene product in AAV muscle gene transfer. Cellular Immunology. 342. 103682–103682. 33 indexed citations
7.
Kumar, Sandeep, Brad E. Hoffman, Cox Terhorst, Ype P. de Jong, & Roland W. Herzog. (2017). The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose. Molecular Therapy. 25(4). 880–891. 61 indexed citations
8.
Zhou, Jie, Michael S. O’Keeffe, Gongxian Liao, et al.. (2016). Design and synthesis of nanofibers of self-assembled de novo glycoconjugates towards mucosal lining restoration and anti-inflammatory drug delivery. Tetrahedron. 72(40). 6078–6083. 10 indexed citations
9.
Perrin, George Q., Irene Zolotukhin, Alexandra Sherman, et al.. (2016). Dynamics of antigen presentation to transgene product-specific CD4+ T cells and of Treg induction upon hepatic AAV gene transfer. Molecular Therapy — Methods & Clinical Development. 3. 16083–16083. 35 indexed citations
10.
Sarkar, Debalina, Moanaro Biswas, Gongxian Liao, et al.. (2014). Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia. Molecular Therapy — Methods & Clinical Development. 1. 14030–14030. 58 indexed citations
11.
Cooper, Mario, Sushrusha Nayak, Brad E. Hoffman, et al.. (2009). Improved Induction of Immune Tolerance to Factor IX by Hepatic AAV-8 Gene Transfer. Human Gene Therapy. 20(7). 767–776. 78 indexed citations
12.
Shah, Samir A., Stephen J. Simpson, Lawrence F. Brown, et al.. (2007). Development of colonic adenocarcinomas in a mouse model of ulcerative colitis. Inflammatory Bowel Diseases. 4(3). 196–202. 3 indexed citations
13.
Poy, Florence, Michael B. Yaffe, Joan Sayós, et al.. (1999). Crystal Structures of the XLP Protein SAP Reveal a Class of SH2 Domains with Extended, Phosphotyrosine-Independent Sequence Recognition. Molecular Cell. 4(4). 555–561. 206 indexed citations
14.
Zubiaur, Mercedes, Marı́a Guirado, Cox Terhorst, Fabio Malavasi, & Jaime Sancho. (1999). The CD3-γδε Transducing Module Mediates CD38-induced Protein-tyrosine Kinase and Mitogen-activated Protein Kinase Activation in Jurkat T Cells. Journal of Biological Chemistry. 274(29). 20633–20642. 34 indexed citations
15.
Shah, Samir A., Stephen J. Simpson, Lawrence F. Brown, et al.. (1998). Development of Colonic Adenocarcinomas in a Mouse Model of Ulcerative Colitis. Inflammatory Bowel Diseases. 4(3). 196–202. 22 indexed citations
16.
Mackay, Fabienne, Jeffrey L. Browning, Samir A. Shah, et al.. (1998). Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology. 115(6). 1464–1475. 131 indexed citations
17.
Guimond, Marie‐Josée, et al.. (1997). Absence of Natural Killer Cells during Murine Pregnancy is Associated with Reproductive Compromise in TgE26 Mice1. Biology of Reproduction. 56(1). 169–179. 221 indexed citations
18.
Exley, Mark A., et al.. (1995). Evidence for multivalent structure of T-cell antigen receptor complex. Molecular Immunology. 32(11). 829–839. 63 indexed citations
19.
Wileman, Thomas, Larry Kane, & Cox Terhorst. (1991). Degradation of T-cell receptor chains in the endoplasmic reticulum is inhibited by inhibitors of cysteine proteases.. PubMed. 2(9). 753–765. 34 indexed citations
20.
Clevers, Hans, Sabrina Dunlap, & Cox Terhorst. (1988). The transmembrane orientation of the ϵ chain of the TcR/CD3 complex. European Journal of Immunology. 18(5). 705–710. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026